Latest news
Loading news…
Replay
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Diego, California, United States Founded 2021 11-50 employees For Profit
Replay is a genome writing company reprogramming biology by writing and delivering big DNA.
Replay was acquired by LEO Pharma in 2026 for $50M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
82
Patents
2
5 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Patents granted
- 2
- Trademarks
- 5
- IT spend
- $1M
Company Info
- Founded
- 2021
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 16
- HQ
- San Diego, California, United States
- Region
- Greater San Diego Area, West Coast, Western US
- Exit date
- Apr 30, 2026
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- -4.9
- Trend (90d)
- 3.1
- Last leadership hire
- May 18, 2023
82
professional contacts at Replay
Contact execs at Replay →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Replay
Loading news…
FAQs about Replay
People who checked this page also checked these
Browse the full Acquirezy directory.